Levon Resources (LVNVF) 0.4850 $LVNVF
Frost Closes SciVac Deal, A Potential Blockbuster Lineup in Hepatitis
ACCESSWIRE - Wed Aug 05, 11:20AM CDT
NEW YORK, NY / ACCESSWIRE / August 5, 2015 / Towards the end of last year, we got word that Dr Phillip Frost, chairman and CEO of Opko Health, Inc. (OPK), was looking to restructure then private company SciVac (now SciVac Therapeutics Inc. (SVACF)) into a public entity. Little more was heard of the matter until March 2015, when gold and precious metals exploration company Levon Resources Ltd announced that it had entered into an agreement pursuant to which Levon would acquire 100% of the issued and outstanding ordinary shares of SciVac. OPKO had a 45% stake in SciVac, and so the deal would see current SciVac owners take 68.4% of the outstanding shares of the new company after its close, and Opko take a little over 30%. At first glance the arrangement can seem a little bit convoluted, but a closer look reveals it is very similar in structure to a number of other public shell spins Frost has orchestrated in the past.
OPK: 10.09 (-0.46)
Levon Provides Update on TSX Listing
Marketwired - Tue Jul 14, 7:31AM CDT
Levon Resources Ltd. (TSX: LVN) (formerly 1027949 B.C. Ltd.) ("Levon" or the "Company"
is pleased to announce that the common shares of Levon (the "Common Shares" have commenced trading on the Toronto Stock Exchange ("TSX" under the stock symbol "LVN" following the completion of the previously announced plan of arrangement (the "Arrangement" involving SciVac Therapeutics Inc. (formerly Levon Resources Ltd.) ("SciVac" or "Old Levon", as the context requires), SciVac Ltd. and the Company dated March 19, 2015. The Company has 119,542,711 Common Shares outstanding as of July 14, 2015. The Company also announced its intention to have the Common Shares quoted on the OTCQX in the United States. A further announcement will be made on such listing being obtained.
LVN.TO: 0.16 (+0.01)
SciVac Announces Listing on the Toronto Stock Exchange
Marketwired - Mon Jul 13, 9:44PM CDT
SciVac Therapeutics Inc. (the "Company", formerly Levon Resources Ltd.) (TSX: VAC)(OTCQX: SVACF) is pleased to announce that the Toronto Stock Exchange (the "TSX" has issued a bulletin confirming the listing of the Company's common shares (the "Common Shares" on the TSX under the symbol "VAC", commencing at the opening of the TSX on July 14, 2015. Also commencing at the opening of markets on July 14, 2015, the Common Shares will be quoted on the OTCQX under the symbol "SVACF".
VAC.TO: 0.27 (unch)
CLS Therapeutics Limited Acquires Shares of SciVac Therapeutics Inc.
CNW Group - Fri Jul 10, 6:42PM CDT
CLS Therapeutics Limited ("CLS" acquired ownership of 147,403,443 common shares ("Common Shares" of SciVac Therapeutics Inc. (the "Company" (formerly Levon Resources Ltd. ("Levon") representing 19.5% of the issued and outstanding Common Shares of the Company effective July 9, 2015. Prior to the transaction, CLS did not own any of the issued and outstanding Common Shares of the Company.
OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources
Business Wire - Fri Jul 10, 8:00AM CDT
OPKO Health, Inc. (NYSE:OPK) is pleased to announce that SciVac Ltd. ("SciVac", an Israeli entity in which OPKO has a forty-five percent ownership interest, completed its previously announced plan of arrangement under Section 288 of the Business Corporations Act (British Columbia) (the "Transaction" with SciVac Therapeutics Inc. (the "Company," formerly Levon Resources Ltd. ("Levon"), pursuant to which the Company acquired 100% of the issued and outstanding securities of SciVac in exchange for common shares of the Company (the "Common Shares". The terms and conditions on which the Transaction was completed were set out in the arrangement agreement dated March 19, 2015 (the "Arrangement Agreement" among Levon, SciVac and 1027949 B.C. Ltd.
OPK: 10.09 (-0.46)
SciVac Announces the Completion of Reverse Takeover Transaction
Marketwired - Thu Jul 09, 8:26AM CDT
SciVac Therapeutics Inc. (the "Company", formerly Levon Resources Ltd.) ("Levon" is pleased to announce the completion of the previously announced plan of arrangement (the "Transaction" pursuant to which SciVac Ltd. ("SciVac" completed a reverse takeover of Levon. In connection with the Transaction, the Company acquired 100% of the issued and outstanding securities of SciVac in exchange for 517,514,016 common shares (the "Common Shares" of the Company, resulting in the former SciVac securityholders holding 68.4% of the issued and outstanding Common Shares and the Levon shareholders immediately prior to the effective time of the Transaction controlling the remaining 31.6%. On completion of the Transaction, the Company changed its name from Levon Resources Ltd. to SciVac Therapeutics Inc.
Levon Announces Completion of Arrangement
Marketwired - Thu Jul 09, 8:26AM CDT
Levon Resources Ltd. (formerly 1027949 B.C. Ltd.) ("Levon" or the "Company" is pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement" pursuant to which, among other things, SciVac Ltd. ("SciVac" completed a reverse takeover of SciVac Therapeutics Inc. (formerly Levon Resources Ltd.) ("New SciVac" or "Old Levon", as the context requires). Pursuant to the Arrangement, among other things, shareholders of Old Levon immediately prior to the Arrangement received one new common share of New SciVac (each, a "New SciVac Share" and 0.5 of a common share of Levon (each, a "Levon Share" in exchange for each common share of Old Levon held by such shareholder immediately prior to the effective time of the Arrangement (the "Effective Time", for a total issuance of 239,085,423 New SciVac Shares and 119,542,711 Levon Shares. As a result of the Arrangement, former shareholders of Old Levon hold 100% of the issued and outstanding Levon Shares immediately after completion of the Arrangement. In connection with the Arrangement, the Company changed its name from "1027949 B.C. Ltd." to "Levon Resources Ltd." immediately after New SciVac changed its name from "Levon Resources Ltd." to "SciVac Therapeutics Inc.". The Company will continue to operate the junior mining business of Old Levon immediately prior to the Arrangement.
Levon Provides Update Regarding Closing of Arrangement With SciVac Ltd.
Marketwired - Thu Jul 02, 1:50PM CDT
Levon Resources Ltd. ("Levon" or the "Company" (TSX: LVN)(OTCQX: LVNVF)(BERLIN: LO9)(FRANKFURT: LO9) is pleased to announce that it has received the conditional approval of the Toronto Stock Exchange ("TSX" for the listing of a new class of common shares (the "New Levon Shares" following the completion of the previously announced plan of arrangement (the "Arrangement" involving SciVac Ltd., Levon and 1027949 B.C. Ltd., which was approved by Levon securityholders on June 3, 2015.
LVN.TO: 0.16 (+0.01)
Levon Obtains Final Order for Plan of Arrangement
Marketwired - Thu Jun 04, 2:01PM CDT
Levon Resources Ltd. ("Levon" or the "Company" (TSX: LVN)(BERLIN: LO9)(FRANKFURT: LO9)(OTCQX: LVNVF) is pleased to announce that the Supreme Court of British Columbia has granted a final order (the "Final Order" approving the previously announced plan of arrangement (the "Arrangement" involving SciVac Ltd., Levon and 1027949 B.C. Ltd. The granting of the Final Order was a condition to the completion of the Arrangement. The Arrangement was approved by Levon securityholders at a special meeting of Levon held on June 3, 2015.
LVN.TO: 0.16 (+0.01)
Levon Shareholders and Optionholders Vote in Favour of the Plan of Arrangement Involving SciVac Ltd. and 1027949 B.C. Ltd.
Marketwired - Wed Jun 03, 1:10PM CDT
Levon Resources Ltd. ("Levon" or the "Company" (TSX: LVN)(BERLIN: LO9)(FRANKFURT: LO9)(OTCQX: LVNVF) is pleased to announce that Levon's shareholders (the "Shareholders" and optionholders (together with the Shareholders, the "Securityholders" have voted today at the special meeting of Securityholders (the "Meeting" to approve the previously announced plan of arrangement (the "Arrangement" involving SciVac Ltd. ("SciVac", Levon and 1027949 B.C. Ltd. The Arrangement was approved by 97.64% of the votes cast by Shareholders and 98.06% of the votes cast by Securityholders, voting together as a single class, at the Meeting.
LVN.TO: 0.16 (+0.01)
Frost Closes SciVac Deal, A Potential Blockbuster Lineup in Hepatitis
ACCESSWIRE - Wed Aug 05, 11:20AM CDT
NEW YORK, NY / ACCESSWIRE / August 5, 2015 / Towards the end of last year, we got word that Dr Phillip Frost, chairman and CEO of Opko Health, Inc. (OPK), was looking to restructure then private company SciVac (now SciVac Therapeutics Inc. (SVACF)) into a public entity. Little more was heard of the matter until March 2015, when gold and precious metals exploration company Levon Resources Ltd announced that it had entered into an agreement pursuant to which Levon would acquire 100% of the issued and outstanding ordinary shares of SciVac. OPKO had a 45% stake in SciVac, and so the deal would see current SciVac owners take 68.4% of the outstanding shares of the new company after its close, and Opko take a little over 30%. At first glance the arrangement can seem a little bit convoluted, but a closer look reveals it is very similar in structure to a number of other public shell spins Frost has orchestrated in the past.
OPK: 10.09 (-0.46)
Levon Provides Update on TSX Listing
Marketwired - Tue Jul 14, 7:31AM CDT
Levon Resources Ltd. (TSX: LVN) (formerly 1027949 B.C. Ltd.) ("Levon" or the "Company"
is pleased to announce that the common shares of Levon (the "Common Shares" have commenced trading on the Toronto Stock Exchange ("TSX" under the stock symbol "LVN" following the completion of the previously announced plan of arrangement (the "Arrangement" involving SciVac Therapeutics Inc. (formerly Levon Resources Ltd.) ("SciVac" or "Old Levon", as the context requires), SciVac Ltd. and the Company dated March 19, 2015. The Company has 119,542,711 Common Shares outstanding as of July 14, 2015. The Company also announced its intention to have the Common Shares quoted on the OTCQX in the United States. A further announcement will be made on such listing being obtained. LVN.TO: 0.16 (+0.01)
SciVac Announces Listing on the Toronto Stock Exchange
Marketwired - Mon Jul 13, 9:44PM CDT
SciVac Therapeutics Inc. (the "Company", formerly Levon Resources Ltd.) (TSX: VAC)(OTCQX: SVACF) is pleased to announce that the Toronto Stock Exchange (the "TSX"
has issued a bulletin confirming the listing of the Company's common shares (the "Common Shares" on the TSX under the symbol "VAC", commencing at the opening of the TSX on July 14, 2015. Also commencing at the opening of markets on July 14, 2015, the Common Shares will be quoted on the OTCQX under the symbol "SVACF". VAC.TO: 0.27 (unch)
CLS Therapeutics Limited Acquires Shares of SciVac Therapeutics Inc.
CNW Group - Fri Jul 10, 6:42PM CDT
CLS Therapeutics Limited ("CLS"
acquired ownership of 147,403,443 common shares ("Common Shares" of SciVac Therapeutics Inc. (the "Company" (formerly Levon Resources Ltd. ("Levon") representing 19.5% of the issued and outstanding Common Shares of the Company effective July 9, 2015. Prior to the transaction, CLS did not own any of the issued and outstanding Common Shares of the Company. OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources
Business Wire - Fri Jul 10, 8:00AM CDT
OPKO Health, Inc. (NYSE:OPK) is pleased to announce that SciVac Ltd. ("SciVac"
, an Israeli entity in which OPKO has a forty-five percent ownership interest, completed its previously announced plan of arrangement under Section 288 of the Business Corporations Act (British Columbia) (the "Transaction" with SciVac Therapeutics Inc. (the "Company," formerly Levon Resources Ltd. ("Levon"), pursuant to which the Company acquired 100% of the issued and outstanding securities of SciVac in exchange for common shares of the Company (the "Common Shares". The terms and conditions on which the Transaction was completed were set out in the arrangement agreement dated March 19, 2015 (the "Arrangement Agreement" among Levon, SciVac and 1027949 B.C. Ltd. OPK: 10.09 (-0.46)
SciVac Announces the Completion of Reverse Takeover Transaction
Marketwired - Thu Jul 09, 8:26AM CDT
SciVac Therapeutics Inc. (the "Company", formerly Levon Resources Ltd.) ("Levon"
is pleased to announce the completion of the previously announced plan of arrangement (the "Transaction" pursuant to which SciVac Ltd. ("SciVac" completed a reverse takeover of Levon. In connection with the Transaction, the Company acquired 100% of the issued and outstanding securities of SciVac in exchange for 517,514,016 common shares (the "Common Shares" of the Company, resulting in the former SciVac securityholders holding 68.4% of the issued and outstanding Common Shares and the Levon shareholders immediately prior to the effective time of the Transaction controlling the remaining 31.6%. On completion of the Transaction, the Company changed its name from Levon Resources Ltd. to SciVac Therapeutics Inc. Levon Announces Completion of Arrangement
Marketwired - Thu Jul 09, 8:26AM CDT
Levon Resources Ltd. (formerly 1027949 B.C. Ltd.) ("Levon" or the "Company"
is pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement" pursuant to which, among other things, SciVac Ltd. ("SciVac" completed a reverse takeover of SciVac Therapeutics Inc. (formerly Levon Resources Ltd.) ("New SciVac" or "Old Levon", as the context requires). Pursuant to the Arrangement, among other things, shareholders of Old Levon immediately prior to the Arrangement received one new common share of New SciVac (each, a "New SciVac Share" and 0.5 of a common share of Levon (each, a "Levon Share" in exchange for each common share of Old Levon held by such shareholder immediately prior to the effective time of the Arrangement (the "Effective Time", for a total issuance of 239,085,423 New SciVac Shares and 119,542,711 Levon Shares. As a result of the Arrangement, former shareholders of Old Levon hold 100% of the issued and outstanding Levon Shares immediately after completion of the Arrangement. In connection with the Arrangement, the Company changed its name from "1027949 B.C. Ltd." to "Levon Resources Ltd." immediately after New SciVac changed its name from "Levon Resources Ltd." to "SciVac Therapeutics Inc.". The Company will continue to operate the junior mining business of Old Levon immediately prior to the Arrangement. Levon Provides Update Regarding Closing of Arrangement With SciVac Ltd.
Marketwired - Thu Jul 02, 1:50PM CDT
Levon Resources Ltd. ("Levon" or the "Company"
(TSX: LVN)(OTCQX: LVNVF)(BERLIN: LO9)(FRANKFURT: LO9) is pleased to announce that it has received the conditional approval of the Toronto Stock Exchange ("TSX" for the listing of a new class of common shares (the "New Levon Shares" following the completion of the previously announced plan of arrangement (the "Arrangement" involving SciVac Ltd., Levon and 1027949 B.C. Ltd., which was approved by Levon securityholders on June 3, 2015. LVN.TO: 0.16 (+0.01)
Levon Obtains Final Order for Plan of Arrangement
Marketwired - Thu Jun 04, 2:01PM CDT
Levon Resources Ltd. ("Levon" or the "Company"
(TSX: LVN)(BERLIN: LO9)(FRANKFURT: LO9)(OTCQX: LVNVF) is pleased to announce that the Supreme Court of British Columbia has granted a final order (the "Final Order" approving the previously announced plan of arrangement (the "Arrangement" involving SciVac Ltd., Levon and 1027949 B.C. Ltd. The granting of the Final Order was a condition to the completion of the Arrangement. The Arrangement was approved by Levon securityholders at a special meeting of Levon held on June 3, 2015. LVN.TO: 0.16 (+0.01)
Levon Shareholders and Optionholders Vote in Favour of the Plan of Arrangement Involving SciVac Ltd. and 1027949 B.C. Ltd.
Marketwired - Wed Jun 03, 1:10PM CDT
Levon Resources Ltd. ("Levon" or the "Company"
(TSX: LVN)(BERLIN: LO9)(FRANKFURT: LO9)(OTCQX: LVNVF) is pleased to announce that Levon's shareholders (the "Shareholders" and optionholders (together with the Shareholders, the "Securityholders" have voted today at the special meeting of Securityholders (the "Meeting" to approve the previously announced plan of arrangement (the "Arrangement" involving SciVac Ltd. ("SciVac", Levon and 1027949 B.C. Ltd. The Arrangement was approved by 97.64% of the votes cast by Shareholders and 98.06% of the votes cast by Securityholders, voting together as a single class, at the Meeting. LVN.TO: 0.16 (+0.01)
